- Home
- TIL vs CNF Comparison
TIL vs CNF Comparison
Compare TIL & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TIL | CNF |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.4M | 53.8M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TIL | CNF |
|---|---|---|
| Price | $7.18 | $2.43 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $125.00 | N/A |
| AVG Volume (30 Days) | 10.3K | ★ 36.9K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $252.34 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.67 | $0.37 |
| 52 Week High | $33.83 | $24.00 |
Technical Indicators
Market Signals| Indicator | TIL | CNF |
|---|---|---|
| Relative Strength Index (RSI) | 37.32 | 43.88 |
| Support Level | $6.85 | $2.20 |
| Resistance Level | $8.30 | $3.49 |
| Average True Range (ATR) | 0.19 | 0.25 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 21.05 | 19.33 |
Price Performance
Historical ComparisonAbout TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, the group generates all of its revenues in the PRC.